Meeder Asset Management Inc Y M Abs Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

  • $1.48 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020
SELL
$35.13 - $43.62 $65,587 - $81,438
-1,867 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$23.66 - $49.53 $34,401 - $72,016
1,454 Added 352.06%
1,867 $81,000
Q1 2020

May 15, 2020
SELL
$14.39 - $35.8 $84,785 - $210,933
-5,892 Reduced 93.45%
413 $11,000
Q4 2019

Feb 13, 2020
BUY
$23.81 - $33.78 $150,122 - $212,982
6,305 New
6,305 $196,000

Others Institutions Holding YMAB

# of Institutions
107
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $417M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email